Evidence map›Paper›PMID 34636065›Full record

ArticleStatistics in medicine2021

Estimating the optimal timing of surgery by imputing potential outcomes.

Xiaofei Chen, Daniel F Heitjan, Gerald Greil, Haekyung Jeon-Slaughter

Open access · greenAbstract read
In one paragraph

Article in Statistics in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xiaofei ChenDepartment of Statistical Science, Southern Methodist University, Dallas, Texas, USA.ORCID 0000-0001-8086-4746
Daniel F HeitjanDepartment of Statistical Science, Southern Methodist University, Dallas, Texas, USA.ORCID 0000-0002-1527-4472
Gerald GreilDepartment of Pediatrics, UT Southwestern Medical Center, Dallas, Texas, USA.
Haekyung Jeon-SlaughterDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Southern Methodist University · USSouthwestern Medical Center · US

Funding

Measuring Sensitivity to NonignorabilityR01HL068074 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HEITJAN, DANIEL F. · 2001 to 2003
$583k
NHLBI NIH HHS R01 HL068074
6 · The paper itself

Abstract

Hypoplastic left heart syndrome is a congenital anomaly that is uniformly fatal in infancy without immediate treatment. The standard treatment consists of an initial Norwood procedure (stage 1) followed some months later by stage 2 palliation (S2P). The ideal timing of the S2P is uncertain. The Single Ventricle Reconstruction Trial (SVRT) randomized the procedure used in the initial Norwood operation, leaving the timing of the S2P to the discretion of the surgical team. To estimate the causal effect of the timing of S2P, we propose to impute the potential post-S2P survival outcomes using statistical models under the Rubin Causal Model framework. With this approach, it is straightforward to estimate the causal effect of S2P timing on post-S2P survival by directly comparing the imputed potential outcomes. Specifically, we consider a lognormal model and a restricted cubic spline model, evaluating their performance in Monte Carlo studies. When applied to the SVRT data, the models give somewhat different imputed values, but both support the conclusion that the optimal time for the S2P is at 6 months after the Norwood procedure.

Indexed as

Hypoplastic Left Heart SyndromeNorwood ProceduresHumansModels, StatisticalPalliative CareRetrospective StudiesTreatment OutcomeBayesian bootstraplognormal modelmultiple imputationpotential outcomerestricted cubic spline

Identifiers

PMID34636065
PMCPMC8671372
OpenAlexW3207252998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.